Schedule 13G ownership disclosure

MIRAGEN THERAPEUTICS, INC.

Security class unavailable · CUSIP: 60463E103

Event date: 2018-12-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-19-000005
Form type
SC 13G
Filer
683 Capital Partners, LP
CIK
CIK 1380126
Filed
Jan 03, 2019
Reporting period
Dec 26, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub